Extensive Intraoperative Peritoneal Lavage After Curative Gastrectomy for Locally Advanced Gastric Cancer (SEIPLUS)
NCT02745509 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 508
Last updated 2019-02-21
Summary
The investigators study aims to explore the potential function of extensive intraoperative peritoneal lavage in improving the overall survival and progression-free survival for locally advanced gastric cancer after curative resection.
Hypothesis: Overall survival and progression-free survival of locally advanced gastric cancer are improved by extensive intraoperative peritoneal lavage.
Conditions
Interventions
- OTHER
-
Extensive Intraoperative Peritoneal Lavage
Extensive Intraoperative Peritoneal Lavage
Sponsors & Collaborators
-
Anhui Provincial Hospital
collaborator OTHER_GOV -
The First Affiliated Hospital of Anhui Medical University
collaborator OTHER -
Anqing Municipal Hospital
collaborator OTHER -
Yuebei People's Hospital
collaborator OTHER -
The First Affiliated Hospital of Guangdong Pharmaceutical University
collaborator OTHER -
Guangdong Provincial Hospital of Traditional Chinese Medicine
collaborator OTHER -
Jiangsu Cancer Institute & Hospital
collaborator OTHER -
Jiangxi Provincial Cancer Hospital
collaborator OTHER -
Tianjin Medical University Cancer Institute and Hospital
collaborator OTHER -
First Affiliated Hospital of Wannan Medical College
collaborator OTHER -
Lishui hospital of Zhejiang University
collaborator UNKNOWN -
Second Affiliated Hospital, School of Medicine, Zhejiang University
collaborator OTHER -
Sun Yat-sen University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-03-31
- Primary Completion
- 2017-11-30
- Completion
- 2017-11-30
Countries
- China
Study Locations
More Related Trials
-
Proximal Gastrectomy vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy
NCT06597227 ·Status: RECRUITING ·Phase: NA
-
Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis
NCT05541146 ·Status: UNKNOWN ·Phase: PHASE2
-
Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric Cancer
NCT01830270 ·Status: TERMINATED ·Phase: PHASE2
-
Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer
NCT06054906 ·Status: RECRUITING ·Phase: PHASE2
-
Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05)
NCT05872685 ·Status: RECRUITING ·Phase: PHASE2
-
Laparoscopic D2 Distal Gastrectomy Following Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancers
NCT03468712 ·Status: UNKNOWN ·Phase: NA
-
Exploratory Clinical Study of Penpulimab Combined With SOX in the Perioperative Treatment of Gastric Cancer
NCT05519202 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Conversion Immunochemotherapy
NCT07056010 ·Status: RECRUITING ·Phase: NA
-
Efficacy of HIPEC Combined With Systemic Chemotherapy and CRS on Peritoneal Metastases From Gastric Cancer
NCT03179579 ·Status: UNKNOWN ·Phase: PHASE3
-
Nonintervention Study on Peritoneal Metastasis of Stage IV Gastric Cancer
NCT03237507 ·Status: UNKNOWN
-
Radical Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer
NCT02528110 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed
NCT06885034 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of S-1 and Oxaliplatin as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
NCT01090505 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis
NCT00149201 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Confirm the Accuracy of Locally Advanced Gastric Cancer Diagnosis
NCT04440605 ·Status: UNKNOWN
-
Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric Cancer
NCT02845986 ·Status: UNKNOWN ·Phase: PHASE2
-
Biomarker Analysis of HIPEC Combined With PD1/PDL1 Inhibitor for Gastric Cancer With Peritoneal Metastasis
NCT05661110 ·Status: NOT_YET_RECRUITING
-
Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer With Peritoneal Metastatis
NCT03604614 ·Status: UNKNOWN ·Phase: PHASE2
-
The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric Cancer
NCT03007446 ·Status: UNKNOWN ·Phase: PHASE2
-
Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer
NCT05497739 ·Status: UNKNOWN ·Phase: PHASE2
-
Robotic Versus Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer
NCT03273920 ·Status: UNKNOWN ·Phase: NA
-
A Phase II Study of Conversion Surgery After IP Paclitaxel With XELOX Chemotherapy in AGC With Peritoneal Dissemination
NCT04797923 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer
NCT00142350 ·Status: COMPLETED ·Phase: PHASE3
-
Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal Junction
NCT01360086 ·Status: COMPLETED ·Phase: PHASE2
-
Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP)
NCT04740346 ·Status: RECRUITING ·Phase: NA